___

1. Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. Bipolar depression: overview and commentary. Harv Rev Psychiatry 2010; 18:143-157.

2. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Washington, DC: American Psychiatric Press, 2013.

3. Baldessarini RJ. Chemotherapy in Psychiatry. Third ed. New York: Springer Science & Business Media, 2013.

4. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. International Society for Bipolar Disorders (ISBD) task-force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170:1249-1262.

5. Baldessarini RJ, Salvatore P, Khalsa HM, Gebre-Medhin P, Imaz H, González-Pinto A, Perez J, Cruz N, Maggini C, Tohen M. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord 2010; 12:264-270.

6. Forte A, Baldessarini RJ, Tondo L, Vázquez GH, Pompili M, Girardi P. Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. J Affect Disord 2015; 178:71-78.

7. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. Second ed. New York: Oxford University Press, 2007.

8. Baldessarini RJ, Tondo L, Vázquez GH, Undurraga J, Bolzani L, Yildiz A, Khalsa HM, Lai M, Lepri B, Lolich M, Maffei PM, Salvatore P, Faedda GL, Vieta E, Tohen M. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry 2012; 11:40-46.

9. Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011; 117:961-977.

10. Salvatore, P, Baldessarini RJ, Centorrino F, Egli S, Albert M, Gerhard A, Maggini C. Weygandt’s On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar manic- depressive disorder. Harv Rev Psychiatry 2002; 10:255-275.

11. Vieta E. Treatment of mixed states and the risk of switching to depression. Eur Psychiatry 2005; 20:96-100.

12. Tondo L, Vázquez GH, Baldessarini RJ. Mania associated with antidepressant-treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010; 121:404-414.

13. Baldessarini RJ, Faedda GL, Offidani E, Vázquez GH, Marangoni C, Serra G, Tondo L. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord 2013; 148:129-135.

14. Yildiz A, Vieta E, Nikodem M, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med 2015; 45:299-317.

15. Tondo L, Baldessarini RJ, Vázquez GH, Lepri B, Visioli C. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand 2013; 127:355-364.

16. Baldessarini RJ, Undurraga J, Vázquez GH, Tondo L, Salvatore P, Ha K, Khalsa HM, Lepri B, Ha TH, Chang JS, Tohen M, Vieta E. Predominant recurrence polarity among 928 adult international bipolar-I disorder patients. Acta Psychiatr Scand 2012; 125:293- 302.

17. Baldessarini RJ, Tondo L, Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand 2014; 129:383-392.

18. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 2010; 71:864-872.

19. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007; 58:85-91.

20. Baldessarini RJ, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 2008; 59:1175-1183.

21. Tondo L, Isacsson G, Baldessarini RJ. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 2003; 17:491-511.

22. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 2005; 293:2487-2495.

23. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: review and meta-analysis of the evidence. Bipolar Disord 2010; 12:1-9.

24. Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 2011; 68:1058-1064.

25. Schaffer A, Isometsä ET, Tondo L, Moreno D, Turecki G, Reis C, Cassidy F, Sinyor M, Azorin JM, Kessing LV, Ha K, Goldstein T, Weizman A, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA Jr, Rihmer Z, Yatham LN. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord 2015; 17:1-16.

26. Tondo L, Baldessarini RJ. Suicide in bipolar disorder. In: Yildiz A, Nemeroff C, Ruiz P (editors). Bipolar Disorder: Millennium Update. New York: Oxford University Press; 2015.

27. Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58:844-850.

28. Hayes JF, Miles J, Walters K, King M, Osborn DP. Systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015; 1-9. (doi: 10.1111/ acps.12438).

29. Baldessarini RJ, Salvatore P, Khalsa HM, Tohen M. Dissimilar morbidity following initial mania vs. mixed-states in type-I bipolar disorder. J Affect Disord 2010; 126:299-302.

30. Koukopoulos A, Reginaldi D, Tondo L, Visioli C, Baldessarini RJ. Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias. J Affect Disord 2013; 151:105- 110.

31. Vázquez G, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta- analytic review. Pharmacopsychiatry 2011; 44:21-26.

32. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 2012; 37:851- 864.

33. Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment in bipolar depression. Intl J Neuropsychopharmacol 2013; 16:1673-1685.

34. Lorenzo LS, Vázquez GH, Zaratiegui RM, Tondo L, Baldessarini RJ. Characteristics of bipolar disorder patients given antidepressants. Hum Psychopharmacol 2012; 27:486-491.

35. Undurraga J. Baldessarini RJ, Valenti M, Pacchiarotti I, Tondo L, Vázquez G, Vieta E. Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord 2012; 139: 89-93.

36. Baldessarini RJ, Faedda GL, Hennen J. Risk of mania with antidepressants. Arch Pediatr Adolesc Med 2005; 159:298-299.

37. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711-1722.

38. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010; 71:163-174.

39. Ghaemi SN, Wingo AP, Filkowski MA, Goodwin FK, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analysis of benefits and risks. Acta Psychiatr Scand 2008; 118:347-356.

40. Laughren TP. Memorandum: Department Of Health And Human Services Public Health Service Food And Drug Administration Center For Drug Evaluation And Research, 2006. http://www. fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf (Date of access: 15 April 2015).

41. Baldessarini RJ, Tondo L, Strombom I, Dominguez S, Fawcett J, Licinio J, Oquendo M, Tollefson G, Valuck, RJ, Tohen M. Ecological Studies of Antidepressant Treatment and Suicidal Risks. Harv Rev Psychiatry 2007; 15:133-145.

30. Koukopoulos A, Reginaldi D, Tondo L, Visioli C, Baldessarini RJ. Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias. J Affect Disord 2013; 151:105- 110.

31. Vázquez G, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta- analytic review. Pharmacopsychiatry 2011; 44:21-26.

32. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 2012; 37:851- 864.

33. Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment in bipolar depression. Intl J Neuropsychopharmacol 2013; 16:1673-1685.

34. Lorenzo LS, Vázquez GH, Zaratiegui RM, Tondo L, Baldessarini RJ. Characteristics of bipolar disorder patients given antidepressants. Hum Psychopharmacol 2012; 27:486-491.

35. Undurraga J. Baldessarini RJ, Valenti M, Pacchiarotti I, Tondo L, Vázquez G, Vieta E. Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord 2012; 139: 89-93.

36. Baldessarini RJ, Faedda GL, Hennen J. Risk of mania with antidepressants. Arch Pediatr Adolesc Med 2005; 159:298-299.

37. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711-1722.

38. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010; 71:163-174.

39. Ghaemi SN, Wingo AP, Filkowski MA, Goodwin FK, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analysis of benefits and risks. Acta Psychiatr Scand 2008; 118:347-356.

40. Laughren TP. Memorandum: Department Of Health And Human Services Public Health Service Food And Drug Administration Center For Drug Evaluation And Research, 2006. http://www. fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf (Date of access: 15 April 2015).

41. Baldessarini RJ, Tondo L, Strombom I, Dominguez S, Fawcett J, Licinio J, Oquendo M, Tollefson G, Valuck, RJ, Tohen M. Ecological Studies of Antidepressant Treatment and Suicidal Risks. Harv Rev Psychiatry 2007; 15:133-145.

45. Baldessarini RJ, Tondo L. Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry 2009; 42:72-75.

46. Gibbons RD, Hur K, Brown CH, Mann JJ. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009; 66:1354-1360.

47. Selle V, Schalkwijk S, Vázquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analysis of placebo- controlled monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry 2014; 47:43-52.